Tempus AI vs UpToDate AI
A detailed comparison to help you choose between Tempus AI and UpToDate AI.
🏆
Verdict: UpToDate AI wins
UpToDate AI scores 4.2/5, edging out Tempus AI at 4.1/5. Physicians and clinicians who want fast, point-of-care decision support whose AI answers stay inside a vetted, clinician-authored evidence base with visible sources.
Tempus AI AI for precision medicine and clinical genomics | UpToDate AI AI clinical decision support resource | |
|---|---|---|
| Rating | 4.1 (1 review) | 4.2 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $1000/mo | From $35/mo |
| Best For | Cancer centers, molecular labs and health systems building precision-oncology programs that need sequencing, interpretation and data products under one roof — and pharma partners buying real-world data access. | Physicians and clinicians who want fast, point-of-care decision support whose AI answers stay inside a vetted, clinician-authored evidence base with visible sources. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | ssoteam features | mobile app |
| Visit Tempus AI → | Visit UpToDate AI → |
Tempus AI
Pros
- + FY2025 revenue of $1.3B with 126% net revenue retention and >$1.1B remaining contract value — verifiable public-company financials, not marketing claims
- + Complete assay portfolio in one relationship: xT/xR comprehensive profiling, xF+ liquid biopsy, MRD monitoring, Ambry hereditary testing and OneOme pharmacogenomics (national launch July 2026)
- + Tempus One answered voice queries against the patient's own clinical and molecular profile in my testing, with report citations instead of generic text
- + Paige Predict extends the platform into digital pathology — 123 biomarkers predicted from standard H&E slides across 16 cancer types (vendor-published validation)
- + Trial matching is built into the report workflow, which is the practical bottleneck for oncology coordinators
Cons
- - No self-serve access, no trial, and no published pricing of any kind — the $1,000 entry figure floating around listings could not be verified
- - Oncology-first scope; primary care and non-oncology specialties have little reason to engage
- - Still net-loss-making (-$245.0M in 2025), and the portfolio is stitched from four recent acquisitions (Ambry, Paige, OneOme, Deep 6)
- - Model-performance and data-library claims are company-published; independent third-party validation is thinner than the press-release volume suggests
- - Enterprise sales motion means long procurement cycles for health systems
UpToDate AI
Pros
- + Expert AI answers are grounded solely in UpToDate's clinician-authored content and surface the underlying topics, which I verified by tracing answers back to sources in testing
- + Content depth is unmatched in clinical decision support: 13,000+ topics, 10,000+ graded recommendations, 39,000+ graphics across 25 specialties
- + Answers preserve graded evidence uncertainty instead of smoothing it into confident prose
- + MobileComplete offline access worked on a ward with no signal, faster to rely on than any AI feature
- + Trainee subscriptions at $219/year put the same clinical content in the hands of residents and students
Cons
- - Expert AI availability varies by region and subscription; classic subscribers may not get it at all
- - $579/year base and $699/year for Pro Plus at time of writing is a real per-physician cost with no meaningful free tier
- - AI is synthesis-only within the UpToDate corpus: no documentation writing, no order entry, no reasoning beyond the editorial base
- - The tier and packaging matrix for who gets Expert AI took me several pages to untangle
- - Scale claims like '2M+ clinicians' are vendor figures without independent audit
Frequently Asked Questions
Which is better, Tempus AI or UpToDate AI?▼
UpToDate AI scores higher at 4.2/5 vs 4.1/5 for Tempus AI, making it the better-rated option in our comparison.
What is the difference between Tempus AI and UpToDate AI?▼
Tempus AI: Tempus AI runs clinical and genomic sequencing and builds the diagnostics and data products used in precision oncology and other specialties. UpToDate AI: Leading clinical decision support platform with AI-enhanced recommendations used by 2M+ clinicians worldwide for point-of-care guidance.
Is Tempus AI or UpToDate AI more affordable?▼
Tempus AI starts at €1000/mo, UpToDate AI starts at €35/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.